“…10,11 Based on a reported prodrug approach, 6 Kurz et al systematically investigated the effect of introduction of different substituents in α-position of the bis(pivaloyloxymethyl) esters of fosmidomycin or FR900098. 12,13,14 Introduction of an -methyl or -phenyl substituent afforded analogues, which exhibited antiplasmodial activities that came close to that of the FR900098 prodrug, while a 3,4-difluorophenylsubstituted analogue was slightly more potent. Consistent with our findings, -aryl-substituted fosmidomycin analogues were generally superior to their FR900098 homologues.…”